QNRX: FDA Clearance To Move QRX003 Clinical Testing Forward; Positive Implications
By M. Marin
NASDAQ:QNRX
READ THE FULL QNRX RESEARCH REPORT
EPIX: Preclinical Data on Androgen Receptor N-Terminal Domain Degrader Presented at AACR…
By David Bautz, PhD
NASDAQ:EPIX
READ THE FULL EPIX RESEARCH REPORT
TRC: Expanding Development Partnership Highlights Company’s Strong Prospects
By M. Marin
NYSE:TRC
READ THE FULL TRC RESEARCH REPORT
ORMP: Broadening IP Protection, Positive Physician Indicators & Studies Advancing
By M. Marin
NASDAQ:ORMP
READ THE FULL ORMP RESEARCH REPORT
Broadening patent IP protection…
NVX: Rising EV Adoption & Charging Infrastructure Buildout Are Positives As NVX Ramps Production Capacity
By M. Marin
NASDAQ:NVX
READ THE FULL NVX RESEARCH REPORT
LEXX: Hypertension Results Raise Stakes
By John Vandermosten, CFA
NASDAQ:LEXX
READ THE FULL LEXX RESEARCH REPORT
QLGN: Secures Worldwide Rights to G4-Selective Cancer Therapeutics…
By David Bautz, PhD
NASDAQ:QLGN
READ THE FULL QLGN RESEARCH REPORT
ALVOF: Alvopetro Energy’s Management Focused on Advancing the Murucututu/Gomo natural gas Project to Production; Operational Capacity of the Gas Processing Facility Scheduled to Increase by 25% in June
By Steven Ralston, CFA
OTC:ALVOF | TSX:ALV.V
READ THE FULL ALVOF RESEARCH REPORT
XDSL: Positioning Platform To Benefit From EV Charging Buildout, Retailer Usage & Consumer Engagement
By M. Marin
OTC:XDSL
READ THE FULL XDSL RESEARCH REPORT
VNRX: VolitionRx Enters into Global License & Supply Agreement with Heska Corp. for Nu.Q Vet Cancer Screening Test. Financial Review of 2021 and Expectations in 2022.
By Steven Ralston, CFA
NYSE:VNRX
READ THE FULL VNRX RESEARCH REPORT